| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.927 | 0.003 | 0.958 | Antioxidant | 0.946 0.003 DBMET02034 0.938 0.003 DBMET02035 0.941 0.003 DBMET02036 0.944 0.003 DBMET02038 0.937 0.003 DBMET02039 0.958 0.003 DBMET02040 | DBMET02040 | |
| 0.847 | 0.003 | 0.869 | Cholesterol antagonist | 0.755 0.005 DBMET02034 0.781 0.004 DBMET02035 0.869 0.003 DBMET02036 0.856 0.003 DBMET02038 0.794 0.004 DBMET02039 0.779 0.004 DBMET02040 | DBMET02036 | |
| 0.834 | 0.002 | 0.904 | Lipid peroxidase inhibitor | 0.848 0.001 DBMET02034 0.842 0.001 DBMET02035 0.85 0.001 DBMET02036 0.855 0.001 DBMET02038 0.846 0.001 DBMET02039 0.904 0.001 DBMET02040 | DBMET02040 | |
| 0.826 | 0.012 | 0.874 | Antiinflammatory | 0.813 0.014 DBMET02034 0.85 0.009 DBMET02035 0.838 0.011 DBMET02036 0.839 0.01 DBMET02038 0.853 0.009 DBMET02039 0.874 0.007 DBMET02040 | DBMET02040 | |
| 0.775 | 0.004 | 0.87 | Lipoxygenase inhibitor | 0.675 0.006 DBMET02034 0.832 0.004 DBMET02035 0.87 0.004 DBMET02036 0.851 0.004 DBMET02038 0.791 0.004 DBMET02039 0.832 0.004 DBMET02040 | DBMET02036 | |
| 0.773 | 0.015 | 0.773 | Transcription factor NF kappa B inhibitor | 0.706 0.02 DBMET02034 0.723 0.018 DBMET02035 0.749 0.016 DBMET02036 0.743 0.017 DBMET02038 0.71 0.019 DBMET02039 0.697 0.021 DBMET02040 | ||
| 0.76 | 0.002 | 0.861 | Peroxidase inhibitor | 0.85 0.001 DBMET02034 0.861 0.001 DBMET02035 0.861 0.001 DBMET02036 0.859 0.001 DBMET02038 0.839 0.001 DBMET02039 0.82 0.002 DBMET02040 | DBMET02036 | |
| 0.726 | 0.027 | 0.748 | Apoptosis agonist | 0.748 0.023 DBMET02034 0.705 0.03 DBMET02035 0.712 0.029 DBMET02036 0.708 0.029 DBMET02038 0.686 0.033 DBMET02039 0.709 0.029 DBMET02040 | DBMET02034 | |
| 0.697 | 0.001 | 0.702 | Cholesterol synthesis inhibitor | 0.588 0.001 DBMET02034 0.698 0.001 DBMET02035 0.702 0.001 DBMET02036 0.685 0.001 DBMET02038 0.642 0.001 DBMET02039 0.558 0.002 DBMET02040 | DBMET02036 | |
| 0.701 | 0.005 | 0.818 | Free radical scavenger | 0.752 0.004 DBMET02034 0.715 0.005 DBMET02035 0.741 0.005 DBMET02036 0.747 0.004 DBMET02038 0.725 0.005 DBMET02039 0.818 0.004 DBMET02040 | DBMET02040 | |
| 0.694 | 0.001 | 0.694 | Vanilloid 1 agonist | 0.504 0.002 DBMET02034 0.518 0.002 DBMET02035 0.647 0.002 DBMET02036 0.613 0.002 DBMET02038 0.433 0.003 DBMET02039 0.363 0.004 DBMET02040 | ||
| 0.69 | 0.004 | 0.713 | NOS3 expression enhancer | 0.676 0.004 DBMET02034 0.679 0.004 DBMET02035 0.693 0.003 DBMET02036 0.701 0.003 DBMET02038 0.676 0.004 DBMET02039 0.713 0.003 DBMET02040 | DBMET02040 | |
| 0.631 | 0.005 | 0.641 | Platelet antagonist | 0.526 0.011 DBMET02034 0.639 0.005 DBMET02035 0.641 0.005 DBMET02036 0.634 0.005 DBMET02038 0.6 0.007 DBMET02039 0.623 0.006 DBMET02040 | DBMET02036 | |
| 0.644 | 0.02 | 0.795 | Cyclophilin D inhibitor | 0.651 0.019 DBMET02034 0.696 0.014 DBMET02035 0.678 0.016 DBMET02036 0.686 0.015 DBMET02038 0.716 0.013 DBMET02039 0.795 0.007 DBMET02040 | DBMET02040 | |
| 0.616 | 0.006 | 0.691 | Hypolipemic | 0.576 0.008 DBMET02034 0.691 0.005 DBMET02035 0.624 0.005 DBMET02036 0.618 0.006 DBMET02038 0.648 0.005 DBMET02039 0.589 0.007 DBMET02040 | DBMET02035 | |
| 0.605 | 0.009 | 0.605 | Apoptosis antagonist | 0.431 0.031 DBMET02034 0.529 0.017 DBMET02035 0.59 0.011 DBMET02036 0.59 0.011 DBMET02038 0.534 0.016 DBMET02039 0.593 0.01 DBMET02040 | ||
| 0.588 | 0.014 | 0.588 | Spasmolytic | 0.463 0.029 DBMET02034 0.554 0.017 DBMET02035 0.583 0.015 DBMET02036 0.577 0.015 DBMET02038 0.572 0.016 DBMET02039 0.532 0.019 DBMET02040 | ||
| 0.576 | 0.009 | 0.695 | Hypoglycemic | 0.592 0.009 DBMET02034 0.59 0.009 DBMET02035 0.586 0.009 DBMET02036 0.589 0.009 DBMET02038 0.617 0.007 DBMET02039 0.695 0.005 DBMET02040 | DBMET02040 | |
| 0.552 | 0.002 | 0.552 | Keratolytic | 0.502 0.002 DBMET02034 0.5 0.002 DBMET02035 0.53 0.002 DBMET02036 0.529 0.002 DBMET02038 0.47 0.003 DBMET02039 0.499 0.002 DBMET02040 | ||
| 0.563 | 0.021 | 0.563 | Immunostimulant | 0.441 0.039 DBMET02034 0.479 0.032 DBMET02035 0.541 0.024 DBMET02036 0.523 0.026 DBMET02038 0.442 0.038 DBMET02039 0.433 0.041 DBMET02040 | ||
| 0.558 | 0.019 | 0.558 | Immunosuppressant | 0.536 0.024 DBMET02034 0.531 0.025 DBMET02035 0.523 0.027 DBMET02036 0.516 0.029 DBMET02038 0.511 0.03 DBMET02039 0.456 0.045 DBMET02040 | ||
| 0.534 | 0.002 | 0.665 | Maillard reaction inhibitor | 0.556 0.002 DBMET02034 0.554 0.002 DBMET02035 0.575 0.002 DBMET02036 0.586 0.002 DBMET02038 0.562 0.002 DBMET02039 0.665 0.001 DBMET02040 | DBMET02040 | |
| 0.515 | 0.015 | 0.555 | Antiamyloidogenic | 0.555 0.011 DBMET02034 0.35 0.039 DBMET02035 0.454 0.021 DBMET02036 0.434 0.024 DBMET02038 0.35 0.039 DBMET02039 0.376 0.033 DBMET02040 | DBMET02034 | |
| 0.484 | 0.034 | 0.512 | Histamine release inhibitor | 0.409 0.071 DBMET02034 0.433 0.058 DBMET02035 0.511 0.025 DBMET02036 0.512 0.025 DBMET02038 0.466 0.042 DBMET02039 0.51 0.025 DBMET02040 | DBMET02038 | |
| 0.467 | 0.034 | 0.467 | Antithrombotic | 0.296 0.091 DBMET02034 0.337 0.069 DBMET02035 0.443 0.039 DBMET02036 0.412 0.046 DBMET02038 0.283 0.1 DBMET02039 0.302 0.086 DBMET02040 | ||
| 0.436 | 0.005 | 0.436 | Insulin sensitizer | 0.255 0.032 DBMET02034 0.402 0.006 DBMET02035 0.377 0.008 DBMET02036 0.356 0.009 DBMET02038 0.422 0.005 DBMET02039 0.35 0.009 DBMET02040 | ||
| 0.422 | 0.007 | 0.422 | Protein kinase stimulant | 0.252 0.026 DBMET02034 0.399 0.008 DBMET02035 0.368 0.01 DBMET02036 0.337 0.013 DBMET02038 0.409 0.008 DBMET02039 0.278 0.02 DBMET02040 | ||
| 0.426 | 0.013 | 0.426 | P-glycoprotein inhibitor | 0.349 0.021 DBMET02034 0.407 0.015 DBMET02035 0.388 0.018 DBMET02036 0.395 0.017 DBMET02038 0.396 0.017 DBMET02039 0.373 0.019 DBMET02040 | ||
| 0.422 | 0.011 | 0.453 | Hepatoprotectant | 0.39 0.014 DBMET02034 0.451 0.01 DBMET02035 0.43 0.011 DBMET02036 0.435 0.01 DBMET02038 0.447 0.01 DBMET02039 0.453 0.009 DBMET02040 | DBMET02040 | |
| 0.412 | 0.002 | 0.412 | Glutathione S-transferase inhibitor | 0.274 0.003 DBMET02034 0.293 0.003 DBMET02035 0.369 0.002 DBMET02036 0.36 0.002 DBMET02038 0.267 0.003 DBMET02039 0.332 0.003 DBMET02040 | ||
| 0.445 | 0.042 | 0.445 | Vasodilator, peripheral | 0.208 0.167 DBMET02034 0.216 0.158 DBMET02035 0.39 0.059 DBMET02036 0.366 0.067 DBMET02038 | ||
| 0.369 | 0.002 | 0.369 | Interferon agonist | 0.338 0.003 DBMET02034 0.306 0.003 DBMET02035 0.361 0.002 DBMET02036 0.345 0.003 DBMET02038 0.27 0.004 DBMET02039 0.267 0.004 DBMET02040 | ||
| 0.372 | 0.028 | 0.372 | Vasodilator | 0.28 0.055 DBMET02034 0.347 0.034 DBMET02035 0.361 0.03 DBMET02036 0.356 0.032 DBMET02038 0.334 0.038 DBMET02039 0.339 0.036 DBMET02040 | ||
| 0.37 | 0.033 | 0.37 | Tumour necrosis factor alpha release inhibitor | 0.349 0.038 DBMET02034 0.241 0.079 DBMET02035 0.295 0.055 DBMET02036 0.293 0.056 DBMET02038 0.225 0.089 DBMET02039 0.233 0.083 DBMET02040 | ||
| 0.344 | 0.008 | 0.357 | Phospholipase A2 inhibitor | 0.217 0.035 DBMET02034 0.288 0.015 DBMET02035 0.357 0.007 DBMET02036 0.331 0.01 DBMET02038 0.258 0.021 DBMET02039 0.299 0.014 DBMET02040 | DBMET02036 | |
| 0.36 | 0.024 | 0.389 | Platelet aggregation inhibitor | 0.233 0.06 DBMET02034 0.27 0.044 DBMET02035 0.371 0.022 DBMET02036 0.355 0.025 DBMET02038 0.228 0.063 DBMET02039 0.389 0.02 DBMET02040 | DBMET02040 | |
| 0.33 | 0.004 | 0.33 | Vanilloid agonist | 0.148 0.011 DBMET02034 0.145 0.011 DBMET02035 0.185 0.008 DBMET02036 0.168 0.009 DBMET02038 0.125 0.016 DBMET02039 0.128 0.015 DBMET02040 | ||
| 0.394 | 0.082 | 0.47 | 5 Hydroxytryptamine release inhibitor | 0.441 0.056 DBMET02034 0.437 0.058 DBMET02035 0.437 0.058 DBMET02036 0.433 0.059 DBMET02038 0.47 0.043 DBMET02039 0.405 0.075 DBMET02040 | DBMET02039 | |
| 0.316 | 0.005 | 0.316 | Beta amyloid protein antagonist | 0.165 0.031 DBMET02034 0.196 0.018 DBMET02035 0.221 0.012 DBMET02036 0.224 0.011 DBMET02038 0.206 0.015 DBMET02039 0.249 0.009 DBMET02040 | ||
| 0.319 | 0.016 | 0.411 | Monophenol monooxygenase inhibitor | 0.251 0.024 DBMET02034 0.274 0.021 DBMET02035 0.384 0.012 DBMET02036 0.365 0.013 DBMET02038 0.301 0.018 DBMET02039 0.411 0.011 DBMET02040 | DBMET02040 | |
| 0.291 | 0.002 | 0.291 | Interferon inducer | 0.278 0.002 DBMET02034 0.239 0.003 DBMET02035 0.281 0.002 DBMET02036 0.265 0.003 DBMET02038 0.202 0.003 DBMET02039 0.185 0.004 DBMET02040 | ||
| 0.294 | 0.008 | 0.454 | Mediator release inhibitor | 0.213 0.013 DBMET02034 0.233 0.011 DBMET02035 0.454 0.004 DBMET02036 0.427 0.005 DBMET02038 0.206 0.014 DBMET02039 0.382 0.005 DBMET02040 | DBMET02036 | |
| 0.296 | 0.011 | 0.495 | 5-Lipoxygenase inhibitor | 0.358 0.007 DBMET02034 0.417 0.005 DBMET02035 0.419 0.005 DBMET02036 0.419 0.005 DBMET02038 0.43 0.005 DBMET02039 0.495 0.004 DBMET02040 | DBMET02040 | |
| 0.306 | 0.021 | 0.376 | Melanin inhibitor | 0.3 0.022 DBMET02034 0.307 0.021 DBMET02035 0.376 0.014 DBMET02036 0.37 0.014 DBMET02038 0.268 0.026 DBMET02039 0.268 0.026 DBMET02040 | DBMET02036 | |
| 0.317 | 0.037 | 0.382 | Nitric oxide antagonist | 0.328 0.035 DBMET02034 0.366 0.03 DBMET02035 0.338 0.034 DBMET02036 0.342 0.033 DBMET02038 0.37 0.029 DBMET02039 0.382 0.028 DBMET02040 | DBMET02040 | |
| 0.305 | 0.03 | 0.305 | Gastrin inhibitor | 0.217 0.123 DBMET02036 0.207 0.138 DBMET02038 | ||
| 0.303 | 0.032 | 0.331 | Growth hormone agonist | 0.17 0.073 DBMET02034 0.21 0.055 DBMET02035 0.331 0.027 DBMET02036 0.311 0.03 DBMET02038 0.197 0.06 DBMET02039 0.225 0.05 DBMET02040 | DBMET02036 | |
| 0.317 | 0.051 | 0.317 | DNA damaging | 0.178 0.136 DBMET02034 0.232 0.091 DBMET02035 0.301 0.056 DBMET02036 0.287 0.063 DBMET02038 0.208 0.109 DBMET02039 0.283 0.064 DBMET02040 | ||
| 0.276 | 0.01 | 0.3 | Expectorant | 0.171 0.028 DBMET02034 0.205 0.019 DBMET02035 0.288 0.009 DBMET02036 0.295 0.009 DBMET02038 0.238 0.014 DBMET02039 0.3 0.009 DBMET02040 | DBMET02040 | |
| 0.262 | 0.004 | 0.347 | Leukotriene antagonist | 0.164 0.009 DBMET02034 0.347 0.003 DBMET02035 0.345 0.003 DBMET02036 0.312 0.004 DBMET02038 0.289 0.004 DBMET02039 0.243 0.004 DBMET02040 | DBMET02035 | |
| 0.283 | 0.032 | 0.368 | Non-steroidal antiinflammatory agent | 0.221 0.056 DBMET02034 0.305 0.027 DBMET02035 0.321 0.024 DBMET02036 0.309 0.026 DBMET02038 0.355 0.019 DBMET02039 0.368 0.017 DBMET02040 | DBMET02040 | |
| 0.277 | 0.035 | 0.36 | DNA methyltransferase I inhibitor | 0.135 0.123 DBMET02034 0.173 0.084 DBMET02035 0.285 0.032 DBMET02036 0.281 0.034 DBMET02038 0.155 0.099 DBMET02039 0.36 0.013 DBMET02040 | DBMET02040 | |
| 0.243 | 0.003 | 0.375 | Thromboxane synthase inhibitor | 0.143 0.004 DBMET02034 0.329 0.003 DBMET02035 0.375 0.002 DBMET02036 0.313 0.003 DBMET02038 0.349 0.003 DBMET02039 0.31 0.003 DBMET02040 | DBMET02036 | |
| 0.265 | 0.028 | 0.586 | Diuretic | 0.335 0.018 DBMET02034 0.518 0.007 DBMET02035 0.459 0.009 DBMET02036 0.468 0.009 DBMET02038 0.586 0.005 DBMET02039 0.558 0.005 DBMET02040 | DBMET02039 | |
| 0.24 | 0.005 | 0.337 | Papain-like protease (SARS coronavirus) inhibitor | 0.284 0.004 DBMET02034 0.285 0.004 DBMET02035 0.285 0.004 DBMET02036 0.293 0.004 DBMET02038 0.302 0.004 DBMET02039 0.337 0.003 DBMET02040 | DBMET02040 | |
| 0.24 | 0.007 | 0.253 | Mucolytic | 0.167 0.024 DBMET02034 0.192 0.015 DBMET02035 0.243 0.007 DBMET02036 0.253 0.006 DBMET02038 0.22 0.01 DBMET02039 0.249 0.006 DBMET02040 | DBMET02038 | |
| 0.339 | 0.108 | 0.394 | Antibacterial | 0.316 0.123 DBMET02034 0.394 0.08 DBMET02035 0.374 0.089 DBMET02036 0.358 0.098 DBMET02038 0.34 0.108 DBMET02039 0.26 0.168 DBMET02040 | DBMET02035 | |
| 0.295 | 0.084 | 0.345 | Sodium/bile acid cotransporter inhibitor | 0.202 0.185 DBMET02034 0.268 0.11 DBMET02035 0.323 0.059 DBMET02036 0.333 0.052 DBMET02038 0.295 0.084 DBMET02039 0.345 0.043 DBMET02040 | DBMET02040 | |
| 0.251 | 0.05 | 0.251 | Anesthetic general | 0.148 0.116 DBMET02034 0.192 0.079 DBMET02035 0.216 0.066 DBMET02036 0.214 0.067 DBMET02038 0.232 0.058 DBMET02039 0.196 0.076 DBMET02040 | ||
| 0.22 | 0.02 | 0.236 | Neurotrophic factor | 0.229 0.017 DBMET02034 0.234 0.015 DBMET02035 0.236 0.015 DBMET02036 0.229 0.017 DBMET02038 0.224 0.018 DBMET02039 0.185 0.035 DBMET02040 | DBMET02036 | |
| 0.237 | 0.037 | 0.284 | Thrombolytic | 0.167 0.07 DBMET02034 0.269 0.029 DBMET02035 0.237 0.037 DBMET02036 0.228 0.04 DBMET02038 0.284 0.027 DBMET02039 0.216 0.045 DBMET02040 | DBMET02039 | |
| 0.223 | 0.026 | 0.439 | Insulin secretagoues | 0.282 0.014 DBMET02034 0.249 0.02 DBMET02035 0.277 0.015 DBMET02036 0.285 0.014 DBMET02038 0.29 0.014 DBMET02039 0.439 0.005 DBMET02040 | DBMET02040 | |
| 0.214 | 0.021 | 0.226 | Arachidonic acid antagonist | 0.203 0.03 DBMET02034 0.204 0.029 DBMET02035 0.221 0.016 DBMET02036 0.22 0.017 DBMET02038 0.21 0.024 DBMET02039 0.226 0.014 DBMET02040 | DBMET02040 | |
| 0.188 | 0.015 | 0.188 | Photosensitizer | 0.103 0.084 DBMET02034 0.119 0.058 DBMET02035 0.173 0.02 DBMET02036 0.163 0.024 DBMET02038 0.103 0.083 DBMET02039 0.139 0.039 DBMET02040 | ||
| 0.18 | 0.008 | 0.243 | Peroxisome proliferator-activated receptor gamma agonist | 0.104 0.025 DBMET02034 0.187 0.008 DBMET02035 0.168 0.009 DBMET02036 0.168 0.009 DBMET02038 0.207 0.006 DBMET02039 0.243 0.005 DBMET02040 | DBMET02040 | |
| 0.23 | 0.06 | 0.326 | DNA methylase inhibitor | 0.142 0.125 DBMET02035 0.242 0.053 DBMET02036 0.24 0.054 DBMET02038 0.326 0.021 DBMET02040 | DBMET02040 | |
| 0.194 | 0.026 | 0.252 | Cell adhesion inhibitor | 0.207 0.023 DBMET02035 0.211 0.022 DBMET02036 0.216 0.021 DBMET02038 0.209 0.022 DBMET02039 0.252 0.015 DBMET02040 | DBMET02040 | |
| 0.267 | 0.101 | 0.307 | Interleukin 2 agonist | 0.213 0.168 DBMET02034 0.247 0.121 DBMET02035 0.307 0.069 DBMET02036 0.289 0.082 DBMET02038 0.235 0.136 DBMET02039 0.23 0.143 DBMET02040 | DBMET02036 | |
| 0.203 | 0.039 | 0.203 | Interleukin 6 antagonist | 0.153 0.084 DBMET02034 0.182 0.053 DBMET02035 0.188 0.049 DBMET02036 0.182 0.053 DBMET02038 0.152 0.087 DBMET02039 | ||
| 0.166 | 0.005 | 0.181 | Peroxisome proliferator-activated receptor alpha agonist | 0.074 0.02 DBMET02034 0.149 0.006 DBMET02035 0.163 0.005 DBMET02036 0.156 0.005 DBMET02038 0.165 0.005 DBMET02039 0.181 0.005 DBMET02040 | DBMET02040 | |
| 0.172 | 0.013 | 0.232 | ABCA1 expression enhancer | 0.232 0.007 DBMET02034 0.192 0.01 DBMET02035 0.175 0.013 DBMET02036 0.181 0.012 DBMET02038 0.175 0.013 DBMET02039 0.166 0.014 DBMET02040 | DBMET02034 | |
| 0.203 | 0.047 | 0.203 | Antipruritic | 0.133 0.117 DBMET02034 0.172 0.071 DBMET02036 0.161 0.083 DBMET02038 0.144 0.101 DBMET02040 | ||
| 0.169 | 0.013 | 0.231 | Electron transport complex I inhibitor | 0.231 0.006 DBMET02034 0.216 0.007 DBMET02035 0.216 0.007 DBMET02036 0.196 0.009 DBMET02038 0.186 0.01 DBMET02039 0.171 0.013 DBMET02040 | DBMET02034 | |
| 0.259 | 0.105 | 0.325 | Caspase 3 stimulant | 0.242 0.119 DBMET02034 0.244 0.117 DBMET02035 0.311 0.073 DBMET02036 0.305 0.076 DBMET02038 0.264 0.101 DBMET02039 0.325 0.068 DBMET02040 | DBMET02040 | |
| 0.157 | 0.01 | 0.157 | Ribonucleoside-diphosphate reductase inhibitor | 0.083 0.023 DBMET02034 0.104 0.018 DBMET02035 0.147 0.012 DBMET02036 0.145 0.012 DBMET02038 0.092 0.021 DBMET02039 0.098 0.019 DBMET02040 | ||
| 0.174 | 0.032 | 0.18 | Farnesoid X receptor antagonist | 0.154 0.048 DBMET02034 0.156 0.046 DBMET02035 0.18 0.029 DBMET02036 0.176 0.031 DBMET02038 0.161 0.041 DBMET02039 0.17 0.035 DBMET02040 | DBMET02036 | |
| 0.198 | 0.058 | 0.23 | Lipocortins synthesis antagonist | 0.138 0.125 DBMET02034 0.174 0.077 DBMET02035 0.222 0.044 DBMET02036 0.217 0.047 DBMET02038 0.177 0.073 DBMET02039 0.23 0.041 DBMET02040 | DBMET02040 | |
| 0.151 | 0.012 | 0.151 | Ribonucleotide reductase inhibitor | 0.082 0.026 DBMET02034 0.101 0.021 DBMET02035 0.141 0.013 DBMET02036 0.138 0.014 DBMET02038 0.09 0.023 DBMET02039 0.096 0.022 DBMET02040 | ||
| 0.142 | 0.004 | 0.149 | Glucose-6-phosphate translocase inhibitor | 0.122 0.004 DBMET02034 0.149 0.003 DBMET02035 0.129 0.004 DBMET02036 0.132 0.004 DBMET02038 0.148 0.003 DBMET02039 0.137 0.004 DBMET02040 | DBMET02035 | |
| 0.244 | 0.113 | 0.343 | Nootropic | 0.343 0.056 DBMET02034 0.208 0.148 DBMET02036 0.22 0.135 DBMET02038 | DBMET02034 | |
| 0.221 | 0.093 | 0.252 | DNA synthesis inhibitor | 0.196 0.129 DBMET02034 0.198 0.126 DBMET02035 0.252 0.065 DBMET02036 0.25 0.066 DBMET02038 0.189 0.139 DBMET02039 0.221 0.093 DBMET02040 | DBMET02036 | |
| 0.214 | 0.088 | 0.215 | Angiogenesis stimulant | 0.172 0.109 DBMET02035 0.215 0.087 DBMET02036 0.19 0.1 DBMET02038 0.164 0.114 DBMET02039 | DBMET02036 | |
| 0.131 | 0.009 | 0.168 | Androgen agonist | 0.124 0.009 DBMET02034 0.166 0.006 DBMET02035 0.134 0.009 DBMET02036 0.144 0.008 DBMET02038 0.168 0.006 DBMET02039 0.15 0.007 DBMET02040 | DBMET02039 | |
| 0.134 | 0.02 | 0.241 | Inducible nitric-oxide synthase inhibitor | 0.113 0.028 DBMET02034 0.239 0.005 DBMET02035 0.174 0.012 DBMET02036 0.174 0.012 DBMET02038 0.241 0.005 DBMET02039 0.171 0.012 DBMET02040 | DBMET02039 | |
| 0.126 | 0.018 | 0.141 | CDC25A inhibitor | 0.104 0.025 DBMET02034 0.13 0.016 DBMET02035 0.141 0.014 DBMET02036 0.129 0.017 DBMET02038 0.113 0.022 DBMET02039 0.086 0.037 DBMET02040 | DBMET02036 | |
| 0.15 | 0.045 | 0.176 | Protein-tyrosine phosphatase 1B inhibitor | 0.143 0.049 DBMET02034 0.155 0.044 DBMET02035 0.176 0.036 DBMET02036 0.173 0.037 DBMET02038 0.135 0.053 DBMET02039 0.154 0.044 DBMET02040 | DBMET02036 | |
| 0.138 | 0.034 | 0.179 | Antineoplastic antibiotic | 0.179 0.025 DBMET02034 0.171 0.026 DBMET02035 0.15 0.031 DBMET02036 0.153 0.03 DBMET02038 0.15 0.031 DBMET02039 0.118 0.039 DBMET02040 | DBMET02034 | |
| 0.109 | 0.005 | 0.135 | Bcl-xL inhibitor | 0.096 0.007 DBMET02034 0.097 0.007 DBMET02035 0.099 0.006 DBMET02036 0.103 0.006 DBMET02038 0.109 0.005 DBMET02039 0.135 0.004 DBMET02040 | DBMET02040 | |
| 0.108 | 0.005 | 0.128 | Peroxisome proliferator-activated receptor delta agonist | 0.045 0.014 DBMET02034 0.105 0.005 DBMET02035 0.119 0.005 DBMET02036 0.12 0.005 DBMET02038 0.095 0.006 DBMET02039 0.128 0.004 DBMET02040 | DBMET02040 | |
| 0.15 | 0.047 | 0.15 | Proteasome inhibitor | 0.131 0.058 DBMET02034 0.096 0.092 DBMET02035 0.124 0.062 DBMET02036 0.121 0.064 DBMET02038 0.097 0.092 DBMET02039 | ||
| 0.107 | 0.005 | 0.107 | Nitric oxide donor | 0.086 0.017 DBMET02034 0.094 0.012 DBMET02035 0.096 0.011 DBMET02036 0.095 0.011 DBMET02038 0.095 0.011 DBMET02039 0.097 0.01 DBMET02040 | ||
| 0.164 | 0.066 | 0.19 | Protein-tyrosine phosphatase inhibitor | 0.15 0.078 DBMET02034 0.166 0.065 DBMET02035 0.19 0.051 DBMET02036 0.185 0.053 DBMET02038 0.147 0.082 DBMET02039 0.17 0.062 DBMET02040 | DBMET02036 | |
| 0.142 | 0.044 | 0.142 | Topoisomerase I inhibitor | 0.089 0.08 DBMET02034 0.116 0.058 DBMET02036 0.118 0.057 DBMET02038 0.134 0.048 DBMET02040 | ||
| 0.101 | 0.004 | 0.173 | Peroxisome proliferator-activated receptor alpha antagonist | 0.022 0.014 DBMET02034 0.085 0.005 DBMET02035 0.099 0.005 DBMET02036 0.103 0.004 DBMET02038 0.109 0.004 DBMET02039 0.173 0.003 DBMET02040 | DBMET02040 | |
| 0.108 | 0.012 | 0.165 | Peroxisome proliferator-activated receptor gamma antagonist | 0.072 0.048 DBMET02034 0.109 0.012 DBMET02035 0.109 0.012 DBMET02036 0.109 0.012 DBMET02038 0.126 0.009 DBMET02039 0.165 0.005 DBMET02040 | DBMET02040 | |
| 0.103 | 0.009 | 0.143 | Glutamate (mGluR6) antagonist | 0.075 0.03 DBMET02034 0.129 0.005 DBMET02035 0.12 0.005 DBMET02036 0.121 0.005 DBMET02038 0.143 0.004 DBMET02039 0.099 0.011 DBMET02040 | DBMET02039 | |
| 0.095 | 0.006 | 0.118 | Prostaglandin EP3 antagonist | 0.027 0.024 DBMET02034 0.046 0.011 DBMET02035 0.076 0.007 DBMET02036 0.075 0.007 DBMET02038 0.044 0.012 DBMET02039 0.118 0.005 DBMET02040 | DBMET02040 | |
| 0.124 | 0.035 | 0.129 | Prolactin inhibitor | 0.084 0.075 DBMET02035 0.129 0.033 DBMET02036 0.121 0.038 DBMET02038 0.09 0.067 DBMET02039 0.109 0.047 DBMET02040 | DBMET02036 | |
| 0.292 | 0.203 | 0.292 | Caspase 9 stimulant | 0.274 0.223 DBMET02036 0.253 0.25 DBMET02038 0.287 0.208 DBMET02040 | ||
| 0.11 | 0.023 | 0.124 | Na+ K+ transporting ATPase inhibitor | 0.122 0.015 DBMET02034 0.116 0.019 DBMET02035 0.119 0.017 DBMET02036 0.12 0.016 DBMET02038 0.121 0.016 DBMET02039 0.124 0.014 DBMET02040 | DBMET02040 | |
| 0.146 | 0.061 | 0.177 | Pregnane X receptor agonist | 0.155 0.045 DBMET02034 0.151 0.052 DBMET02035 0.173 0.024 DBMET02036 0.177 0.02 DBMET02038 0.164 0.032 DBMET02039 0.166 0.03 DBMET02040 | DBMET02038 | |
| 0.113 | 0.033 | 0.113 | Topoisomerase II alpha inhibitor | 0.088 0.047 DBMET02034 0.083 0.051 DBMET02035 0.099 0.04 DBMET02036 0.098 0.041 DBMET02038 0.074 0.058 DBMET02039 0.091 0.045 DBMET02040 | ||
| 0.095 | 0.017 | 0.095 | Antimetabolite | 0.065 0.024 DBMET02035 0.075 0.02 DBMET02036 0.069 0.022 DBMET02038 0.057 0.027 DBMET02039 0.056 0.028 DBMET02040 | ||
| 0.178 | 0.1 | 0.263 | Neurotrophic factor enhancer | 0.237 0.046 DBMET02034 0.234 0.049 DBMET02035 0.252 0.037 DBMET02036 0.257 0.035 DBMET02038 0.258 0.034 DBMET02039 0.263 0.032 DBMET02040 | DBMET02040 | |
| 0.08 | 0.008 | 0.08 | Squalene synthetase inhibitor | 0.055 0.013 DBMET02034 0.08 0.008 DBMET02035 0.073 0.009 DBMET02036 0.072 0.009 DBMET02038 0.041 0.018 DBMET02039 | ||
| 0.088 | 0.017 | 0.093 | Transcription factor AP-1 inhibitor | 0.055 0.054 DBMET02034 0.073 0.028 DBMET02035 0.073 0.027 DBMET02036 0.076 0.024 DBMET02038 0.073 0.027 DBMET02039 0.093 0.015 DBMET02040 | DBMET02040 | |
| 0.078 | 0.007 | 0.1 | Pregnane X receptor antagonist | 0.066 0.019 DBMET02034 0.067 0.018 DBMET02035 0.079 0.007 DBMET02036 0.08 0.006 DBMET02038 0.073 0.011 DBMET02039 0.1 0.004 DBMET02040 | DBMET02040 | |
| 0.107 | 0.037 | 0.14 | Ornithine decarboxylase inhibitor | 0.102 0.043 DBMET02034 0.116 0.029 DBMET02035 0.14 0.014 DBMET02036 0.134 0.017 DBMET02038 0.12 0.026 DBMET02039 0.125 0.022 DBMET02040 | DBMET02036 | |
| 0.218 | 0.15 | 0.246 | Angiogenesis inhibitor | 0.19 0.181 DBMET02034 0.213 0.155 DBMET02036 0.218 0.15 DBMET02038 0.246 0.126 DBMET02040 | DBMET02040 | |
| 0.076 | 0.009 | 0.076 | Retinoid X receptor agonist | 0.048 0.019 DBMET02035 0.067 0.011 DBMET02036 0.071 0.01 DBMET02038 0.043 0.021 DBMET02039 0.069 0.011 DBMET02040 | ||
| 0.115 | 0.047 | 0.115 | Gastric antisecretory | |||
| 0.077 | 0.01 | 0.098 | Adenine nucleotide translocase inhibitor | 0.089 0.006 DBMET02034 0.094 0.005 DBMET02035 0.098 0.005 DBMET02036 0.097 0.005 DBMET02038 0.076 0.011 DBMET02039 0.077 0.01 DBMET02040 | DBMET02036 | |
| 0.172 | 0.106 | 0.209 | Anticonvulsant | 0.209 0.076 DBMET02035 0.169 0.108 DBMET02036 0.178 0.101 DBMET02038 0.195 0.087 DBMET02039 | DBMET02035 | |
| 0.142 | 0.077 | 0.185 | Adenylate cyclase stimulant | 0.148 0.066 DBMET02034 0.156 0.053 DBMET02035 0.184 0.023 DBMET02036 0.181 0.025 DBMET02038 0.162 0.044 DBMET02039 0.185 0.022 DBMET02040 | DBMET02040 | |
| 0.112 | 0.048 | 0.147 | Anabolic | 0.095 0.07 DBMET02034 0.109 0.051 DBMET02035 0.126 0.034 DBMET02036 0.122 0.037 DBMET02038 0.114 0.046 DBMET02039 0.147 0.019 DBMET02040 | DBMET02040 | |
| 0.071 | 0.007 | 0.133 | Leukotriene D4 antagonist | 0.05 0.01 DBMET02034 0.12 0.005 DBMET02035 0.133 0.005 DBMET02036 0.13 0.005 DBMET02038 0.111 0.005 DBMET02039 0.13 0.005 DBMET02040 | DBMET02036 | |
| 0.139 | 0.079 | 0.153 | Ca2+-transporting ATPase inhibitor | 0.139 0.078 DBMET02034 0.138 0.081 DBMET02035 0.146 0.053 DBMET02036 0.143 0.064 DBMET02038 0.139 0.079 DBMET02039 0.153 0.036 DBMET02040 | DBMET02040 | |
| 0.075 | 0.017 | 0.107 | Leukotriene B4 antagonist | 0.056 0.034 DBMET02034 0.107 0.009 DBMET02035 0.105 0.009 DBMET02036 0.094 0.012 DBMET02038 0.086 0.014 DBMET02039 0.074 0.018 DBMET02040 | DBMET02035 | |
| 0.101 | 0.047 | 0.112 | Bile acid receptor antagonist | 0.09 0.075 DBMET02035 0.112 0.029 DBMET02036 0.109 0.032 DBMET02038 0.095 0.062 DBMET02039 0.112 0.028 DBMET02040 | DBMET02040 | |
| 0.142 | 0.09 | 0.15 | Interferon gamma antagonist | 0.15 0.077 DBMET02036 0.145 0.085 DBMET02038 0.132 0.107 DBMET02040 | DBMET02036 | |
| 0.085 | 0.036 | 0.205 | Prostaglandin-E synthase inhibitor | 0.073 0.045 DBMET02034 0.145 0.013 DBMET02035 0.142 0.013 DBMET02036 0.135 0.015 DBMET02038 0.167 0.009 DBMET02039 0.205 0.005 DBMET02040 | DBMET02040 | |
| 0.103 | 0.055 | 0.192 | Nitric-oxide synthase inhibitor | 0.12 0.037 DBMET02034 0.185 0.012 DBMET02035 0.149 0.023 DBMET02036 0.148 0.023 DBMET02038 0.192 0.011 DBMET02039 0.168 0.017 DBMET02040 | DBMET02039 | |
| 0.053 | 0.006 | 0.065 | HMG CoA reductase inhibitor | 0.048 0.008 DBMET02034 0.063 0.004 DBMET02035 0.052 0.006 DBMET02036 0.052 0.006 DBMET02038 0.065 0.004 DBMET02039 0.053 0.006 DBMET02040 | DBMET02039 | |
| 0.061 | 0.014 | 0.061 | Microtubule stabilization | 0.056 0.02 DBMET02034 0.055 0.022 DBMET02035 0.057 0.019 DBMET02036 0.057 0.018 DBMET02038 0.053 0.024 DBMET02039 0.054 0.022 DBMET02040 | ||
| 0.098 | 0.051 | 0.098 | Thioredoxin inhibitor | 0.088 0.065 DBMET02036 0.083 0.075 DBMET02038 | ||
| 0.163 | 0.122 | 0.163 | Histone acetyltransferase inhibitor | 0.155 0.132 DBMET02040 | ||
| 0.12 | 0.08 | 0.237 | Cyclooxygenase 1 inhibitor | 0.131 0.07 DBMET02034 0.174 0.046 DBMET02035 0.19 0.039 DBMET02036 0.195 0.036 DBMET02038 0.184 0.041 DBMET02039 0.237 0.024 DBMET02040 | DBMET02040 | |
| 0.103 | 0.064 | 0.103 | Toll-Like receptor 4 antagonist | |||
| 0.044 | 0.007 | 0.068 | Thiazolidinedione | 0.055 0.004 DBMET02034 0.053 0.005 DBMET02035 0.053 0.005 DBMET02036 0.054 0.005 DBMET02038 0.056 0.004 DBMET02039 0.068 0.004 DBMET02040 | DBMET02040 | |
| 0.078 | 0.042 | 0.122 | Glycine receptor agonist | 0.084 0.034 DBMET02034 0.092 0.026 DBMET02035 0.122 0.012 DBMET02036 0.119 0.013 DBMET02038 0.1 0.021 DBMET02039 0.094 0.025 DBMET02040 | DBMET02036 | |
| 0.064 | 0.029 | 0.064 | Lipocortins synthesis agonist | 0.054 0.053 DBMET02034 0.058 0.041 DBMET02036 0.057 0.042 DBMET02038 | ||
| 0.11 | 0.075 | 0.136 | Estrogen antagonist | 0.128 0.041 DBMET02034 0.124 0.047 DBMET02035 0.128 0.042 DBMET02036 0.128 0.042 DBMET02038 0.127 0.043 DBMET02039 0.136 0.031 DBMET02040 | DBMET02040 | |
| 0.038 | 0.005 | 0.038 | Toll-Like receptor 4 agonist | 0.029 0.013 DBMET02034 0.029 0.013 DBMET02035 0.032 0.009 DBMET02036 0.031 0.01 DBMET02038 0.027 0.018 DBMET02039 0.027 0.017 DBMET02040 | ||
| 0.038 | 0.007 | 0.041 | Retinoic acid receptor agonist | 0.03 0.01 DBMET02034 0.033 0.009 DBMET02035 0.035 0.008 DBMET02036 0.035 0.008 DBMET02038 0.032 0.009 DBMET02039 0.041 0.006 DBMET02040 | DBMET02040 | |
| 0.098 | 0.067 | 0.169 | Bronchodilator | 0.107 0.055 DBMET02034 0.115 0.048 DBMET02035 0.126 0.041 DBMET02036 0.121 0.044 DBMET02038 0.119 0.045 DBMET02039 0.169 0.025 DBMET02040 | DBMET02040 | |
| 0.118 | 0.088 | 0.152 | Bone formation stimulant | 0.117 0.088 DBMET02034 0.13 0.077 DBMET02035 0.152 0.057 DBMET02036 0.145 0.063 DBMET02038 | DBMET02036 | |
| 0.094 | 0.065 | 0.108 | Lanosterol 14 alpha demethylase inhibitor | 0.086 0.079 DBMET02034 0.084 0.082 DBMET02035 0.108 0.044 DBMET02036 0.102 0.053 DBMET02038 0.091 0.07 DBMET02039 0.085 0.081 DBMET02040 | DBMET02036 | |
| 0.046 | 0.019 | 0.046 | Membrane dipeptidase inhibitor | 0.04 0.026 DBMET02035 0.044 0.021 DBMET02036 0.041 0.024 DBMET02038 | ||
| 0.046 | 0.02 | 0.046 | 5-Alpha-reductase inhibitor | 0.042 0.023 DBMET02036 0.04 0.024 DBMET02038 0.033 0.03 DBMET02039 | ||
| 0.096 | 0.072 | 0.127 | Estrogen receptor beta antagonist | 0.114 0.04 DBMET02034 0.11 0.046 DBMET02035 0.116 0.037 DBMET02036 0.117 0.035 DBMET02038 0.112 0.043 DBMET02039 0.127 0.025 DBMET02040 | DBMET02040 | |
| 0.027 | 0.006 | 0.033 | Prostacyclin agonist | 0.017 0.01 DBMET02035 0.033 0.005 DBMET02036 0.029 0.006 DBMET02038 | DBMET02036 | |
| 0.138 | 0.118 | 0.163 | Amyloid beta aggregation inhibitor | 0.163 0.099 DBMET02034 0.155 0.104 DBMET02036 0.136 0.12 DBMET02038 0.14 0.116 DBMET02040 | DBMET02034 | |
| 0.054 | 0.036 | 0.054 | Acetyl-CoA transferase inhibitor | |||
| 0.054 | 0.036 | 0.054 | Elastase inhibitor | |||
| 0.091 | 0.074 | 0.091 | Protease inhibitor | |||
| 0.035 | 0.018 | 0.043 | ATP citrate lysase inhibitor | 0.042 0.012 DBMET02035 0.039 0.014 DBMET02036 0.035 0.018 DBMET02038 0.043 0.011 DBMET02039 0.032 0.021 DBMET02040 | DBMET02039 | |
| 0.036 | 0.019 | 0.103 | Peroxisome proliferator-activated receptor delta antagonist | 0.045 0.011 DBMET02035 0.042 0.013 DBMET02036 0.044 0.012 DBMET02038 0.045 0.011 DBMET02039 0.103 0.005 DBMET02040 | DBMET02040 | |
| 0.061 | 0.045 | 0.061 | Caspase 9 inhibitor | |||
| 0.052 | 0.036 | 0.057 | Aconitate hydratase inhibitor | 0.047 0.044 DBMET02035 0.057 0.029 DBMET02036 0.054 0.032 DBMET02038 0.05 0.039 DBMET02039 0.052 0.035 DBMET02040 | DBMET02036 | |
| 0.033 | 0.019 | 0.038 | Prostaglandin D2 agonist | 0.038 0.014 DBMET02036 0.035 0.016 DBMET02038 | DBMET02036 | |
| 0.057 | 0.043 | 0.057 | Prostaglandin EP2 antagonist | 0.052 0.049 DBMET02036 | ||
| 0.055 | 0.042 | 0.072 | Leukotriene C antagonist | 0.058 0.034 DBMET02035 0.066 0.019 DBMET02036 0.064 0.022 DBMET02038 0.059 0.031 DBMET02039 0.072 0.012 DBMET02040 | DBMET02040 | |
| 0.047 | 0.034 | 0.061 | Glucose-6-phosphate isomerase inhibitor | 0.05 0.03 DBMET02035 0.056 0.022 DBMET02036 0.055 0.023 DBMET02038 0.052 0.026 DBMET02039 0.061 0.018 DBMET02040 | DBMET02040 | |
| 0.051 | 0.039 | 0.062 | Vanilloid 2 antagonist | 0.062 0.021 DBMET02034 0.059 0.025 DBMET02035 0.059 0.025 DBMET02036 0.055 0.03 DBMET02038 0.057 0.026 DBMET02039 0.062 0.02 DBMET02040 | DBMET02040 | |
| 0.021 | 0.011 | 0.026 | Retinoic acid receptor antagonist | 0.018 0.013 DBMET02035 0.019 0.013 DBMET02036 0.019 0.012 DBMET02038 0.019 0.013 DBMET02039 0.026 0.007 DBMET02040 | DBMET02040 | |
| 0.063 | 0.053 | 0.113 | Phosphofructokinase-1 inhibitor | 0.082 0.04 DBMET02035 0.107 0.029 DBMET02036 0.105 0.03 DBMET02038 0.094 0.034 DBMET02039 0.113 0.027 DBMET02040 | DBMET02040 | |
| 0.032 | 0.022 | 0.042 | Glutamate (mGluR3) agonist | 0.035 0.016 DBMET02035 0.039 0.011 DBMET02036 0.042 0.008 DBMET02038 0.041 0.009 DBMET02039 0.037 0.013 DBMET02040 | DBMET02038 | |
| 0.021 | 0.013 | 0.021 | Inosine monophosphate dehydrogenase 1 inhibitor | 0.018 0.016 DBMET02040 | ||
| 0.094 | 0.086 | 0.1 | Nav1.4 sodium channel blocker | 0.1 0.076 DBMET02036 0.093 0.087 DBMET02038 | DBMET02036 | |
| 0.039 | 0.03 | 0.039 | VCAM-1 antagonist | |||
| 0.097 | 0.089 | 0.128 | DNA polymerase I inhibitor | 0.128 0.062 DBMET02036 0.115 0.073 DBMET02038 | DBMET02036 | |
| 0.038 | 0.031 | 0.038 | VCAM antagonist | |||
| 0.072 | 0.065 | 0.107 | Cell adhesion molecule inhibitor | 0.088 0.044 DBMET02035 0.082 0.05 DBMET02036 0.084 0.048 DBMET02038 0.091 0.042 DBMET02039 0.107 0.03 DBMET02040 | DBMET02040 | |
| 0.028 | 0.021 | 0.03 | 1,3-Beta-glucan synthase inhibitor | 0.03 0.015 DBMET02034 0.029 0.018 DBMET02035 0.03 0.016 DBMET02036 0.029 0.019 DBMET02038 | DBMET02036 | |
| 0.06 | 0.055 | 0.102 | Leukotriene synthesis inhibitor | 0.078 0.038 DBMET02035 0.093 0.03 DBMET02036 0.087 0.033 DBMET02038 0.084 0.035 DBMET02039 0.102 0.025 DBMET02040 | DBMET02040 | |
| 0.026 | 0.021 | 0.048 | Leukotriene B4 receptor 1 antagonist | 0.048 0.008 DBMET02035 0.037 0.013 DBMET02036 0.031 0.017 DBMET02038 0.048 0.008 DBMET02039 0.041 0.011 DBMET02040 | DBMET02039 | |
| 0.029 | 0.025 | 0.029 | Prostaglandin agonist | |||
| 0.062 | 0.059 | 0.062 | Elastase 1 inhibitor | |||
| 0.034 | 0.03 | 0.039 | Glutamate (mGluR8) antagonist | 0.038 0.021 DBMET02035 0.036 0.023 DBMET02036 0.036 0.023 DBMET02038 0.039 0.018 DBMET02039 | DBMET02039 | |
| 0.016 | 0.013 | 0.016 | Vitamin D receptor agonist | |||
| 0.019 | 0.016 | 0.024 | Toll-Like receptor 8 agonist | 0.024 0.007 DBMET02034 0.019 0.017 DBMET02036 | DBMET02034 | |
| 0.039 | 0.036 | 0.039 | HIV-1 protease inhibitor | 0.039 0.037 DBMET02034 0.039 0.037 DBMET02036 0.039 0.037 DBMET02038 | ||
| 0.029 | 0.026 | 0.029 | Elastase 3A inhibitor | |||
| 0.029 | 0.026 | 0.029 | Elastase 3B inhibitor | |||
| 0.029 | 0.026 | 0.029 | Elastase 2B inhibitor | |||
| 0.138 | 0.136 | 0.21 | Succinate dehydrogenase inhibitor | 0.202 0.047 DBMET02035 0.175 0.073 DBMET02036 0.17 0.08 DBMET02038 0.21 0.042 DBMET02039 0.196 0.052 DBMET02040 | DBMET02039 | |
| 0.045 | 0.043 | 0.046 | Collagenase inhibitor | 0.045 0.044 DBMET02035 0.046 0.043 DBMET02039 | DBMET02039 | |
| 0.05 | 0.048 | 0.058 | Sphingosine 1-phosphate receptor 5 agonist | 0.05 0.046 DBMET02036 0.058 0.028 DBMET02040 | DBMET02040 | |
| 0.055 | 0.055 | 0.067 | Prostaglandin F2 alpha antagonist | 0.067 0.036 DBMET02036 0.059 0.047 DBMET02038 | DBMET02036 | |
| 0.133 | 0.133 | 0.162 | Psychostimulant | 0.162 0.106 DBMET02036 0.149 0.117 DBMET02038 0.151 0.115 DBMET02040 | DBMET02036 | |
| 0.044 | 0.046 | 0.057 | Prostaglandin antagonist | 0.052 0.038 DBMET02036 0.05 0.039 DBMET02038 0.057 0.034 DBMET02040 | DBMET02040 | |
| 0.048 | 0.052 | 0.084 | HIV-1 integrase (Strand Transfer) inhibitor | 0.066 0.038 DBMET02035 0.074 0.034 DBMET02036 0.076 0.033 DBMET02038 0.078 0.032 DBMET02039 0.084 0.029 DBMET02040 | DBMET02040 | |
| 0.035 | 0.04 | 0.05 | Leukotriene C4 antagonist | 0.037 0.033 DBMET02035 0.043 0.018 DBMET02036 0.041 0.021 DBMET02038 0.038 0.03 DBMET02039 0.05 0.011 DBMET02040 | DBMET02040 | |
| 0.027 | 0.035 | 0.043 | Retinoid X alpha receptor agonist | 0.043 0.018 DBMET02040 | DBMET02040 | |
| 0.051 | 0.06 | 0.084 | HIV-1 integrase (3'-Processing) inhibitor | 0.064 0.043 DBMET02035 0.071 0.038 DBMET02036 0.072 0.038 DBMET02038 0.072 0.038 DBMET02039 0.084 0.032 DBMET02040 | DBMET02040 | |
| 0.021 | 0.031 | 0.024 | Vanilloid 2 agonist | 0.024 0.02 DBMET02035 0.024 0.02 DBMET02036 0.024 0.02 DBMET02039 | DBMET02039 | |
| 0.008 | 0.02 | 0.013 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 0.013 0.012 DBMET02039 | DBMET02039 | |
| 0.017 | 0.033 | 0.023 | Prostaglandin F2 alpha agonist | 0.023 0.015 DBMET02036 0.021 0.019 DBMET02038 | DBMET02036 | |
| 0.009 | 0.027 | 0.016 | G-protein-coupled receptor 120 agonist | 0.016 0.013 DBMET02040 | DBMET02040 | |
| 0.182 | 0.2 | 0.248 | Vasodilator, coronary | 0.198 0.184 DBMET02035 0.244 0.14 DBMET02039 0.248 0.137 DBMET02040 | DBMET02040 | |
| 0.009 | 0.03 | 0.05 | Free fatty acid receptor 1 agonist | 0.05 0.005 DBMET02040 | DBMET02040 | |
| 0.171 | 0.197 | 0.287 | Tyrosine 3 hydroxylase inhibitor | 0.208 0.122 DBMET02035 0.235 0.083 DBMET02036 0.252 0.066 DBMET02038 0.24 0.078 DBMET02039 0.287 0.04 DBMET02040 | DBMET02040 | |
| 0.058 | 0.088 | 0.086 | GABA aminotransferase inhibitor | 0.076 0.052 DBMET02036 0.086 0.039 DBMET02038 0.08 0.046 DBMET02039 0.079 0.048 DBMET02040 | DBMET02038 | |
| 0.071 | 0.104 | 0.094 | Estrogen-related receptor beta agonist | 0.094 0.033 DBMET02034 0.08 0.067 DBMET02038 0.086 0.05 DBMET02039 | DBMET02034 | |
| 0.055 | 0.088 | 0.083 | Glutamate dehydrogenase inhibitor | 0.073 0.052 DBMET02036 0.075 0.05 DBMET02038 0.068 0.059 DBMET02039 0.083 0.042 DBMET02040 | DBMET02040 | |
| 0.052 | 0.086 | 0.069 | Aminopeptidase I inhibitor | 0.069 0.055 DBMET02039 | DBMET02039 | |
| 0.074 | 0.108 | 0.085 | Interleukin 1 beta converting enzyme inhibitor | 0.085 0.081 DBMET02038 | DBMET02038 | |
| 0.032 | 0.067 | 0.055 | Thromboxane antagonist | 0.055 0.037 DBMET02036 0.047 0.045 DBMET02038 0.054 0.037 DBMET02040 | DBMET02036 | |
| 0.127 | 0.162 | 0.166 | Phospholipase C inhibitor | 0.166 0.078 DBMET02036 0.157 0.093 DBMET02038 0.143 0.121 DBMET02040 | DBMET02036 | |
| 0.036 | 0.072 | 0.052 | Aminopeptidase microsomal inhibitor | 0.052 0.046 DBMET02035 0.052 0.045 DBMET02039 | DBMET02039 | |
| 0.027 | 0.063 | 0.042 | Retinoid X receptor antagonist | 0.042 0.02 DBMET02040 | DBMET02040 | |
| 0.008 | 0.048 | 0.016 | Thyroid hormone alpha antagonist | 0.016 0.01 DBMET02040 | DBMET02040 | |
| 0.053 | 0.094 | 0.092 | HIV-1 integrase inhibitor | 0.064 0.057 DBMET02036 0.067 0.053 DBMET02038 0.092 0.03 DBMET02040 | DBMET02040 | |
| 0.143 | 0.184 | 0.223 | Cardiotonic | 0.223 0.101 DBMET02039 0.221 0.102 DBMET02040 | DBMET02039 | |
| 0.05 | 0.092 | 0.063 | Potassium channel large-conductance Ca-activated activator | 0.063 0.053 DBMET02040 | DBMET02040 | |
| 0.003 | 0.047 | 0.009 | Integrin alphaVbeta5 antagonist | 0.009 0.007 DBMET02040 | DBMET02040 | |
| 0.023 | 0.068 | 0.034 | Retinoid X alpha receptor antagonist | 0.034 0.024 DBMET02040 | DBMET02040 | |
| 0.074 | 0.12 | 0.138 | Chelator | 0.107 0.068 DBMET02036 0.104 0.071 DBMET02038 0.092 0.089 DBMET02039 0.138 0.04 DBMET02040 | DBMET02040 | |
| 0.016 | 0.062 | 0.058 | Thyroid hormone agonist | 0.034 0.009 DBMET02036 0.036 0.008 DBMET02038 0.028 0.015 DBMET02039 0.058 0.004 DBMET02040 | DBMET02040 | |
| 0.026 | 0.072 | 0.039 | Retinoic acid alpha receptor agonist | 0.039 0.027 DBMET02040 | DBMET02040 | |
| 0.023 | 0.072 | 0.037 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.037 0.026 DBMET02034 | DBMET02034 | |
| 0.068 | 0.119 | 0.178 | GABA C receptor agonist | 0.093 0.075 DBMET02036 0.106 0.061 DBMET02038 0.178 0.025 DBMET02040 | DBMET02040 | |
| 0.033 | 0.084 | 0.061 | Argininosuccinate synthase inhibitor | 0.051 0.045 DBMET02038 0.061 0.036 DBMET02039 0.061 0.036 DBMET02040 | DBMET02040 | |
| 0.031 | 0.082 | 0.058 | DNA gyrase subunit A inhibitor | 0.039 0.038 DBMET02035 0.039 0.038 DBMET02036 0.041 0.032 DBMET02038 0.044 0.026 DBMET02039 0.058 0.011 DBMET02040 | DBMET02040 | |
| 0.026 | 0.08 | 0.08 | Aldose reductase inhibitor | 0.08 0.023 DBMET02040 | DBMET02040 | |
| 0.058 | 0.113 | 0.088 | Estrogen receptor alpha antagonist | 0.072 0.063 DBMET02036 0.073 0.062 DBMET02038 0.088 0.038 DBMET02040 | DBMET02040 | |
| 0.016 | 0.075 | 0.031 | Fumarate hydratase inhibitor | 0.031 0.027 DBMET02040 | DBMET02040 | |
| 0.023 | 0.084 | 0.043 | Thromboxane A2 antagonist | 0.043 0.042 DBMET02040 | DBMET02040 | |
| 0.056 | 0.121 | 0.104 | Aminopeptidase B inhibitor | 0.098 0.066 DBMET02035 0.104 0.062 DBMET02039 | DBMET02039 | |
| 0.003 | 0.072 | 0.016 | Thyroid hormone beta agonist | 0.016 0.004 DBMET02040 | DBMET02040 | |
| 0.083 | 0.153 | 0.178 | Cyclooxygenase inhibitor | 0.142 0.077 DBMET02035 0.13 0.088 DBMET02036 0.135 0.083 DBMET02038 0.153 0.068 DBMET02039 0.178 0.052 DBMET02040 | DBMET02040 | |
| 0.061 | 0.132 | 0.107 | Triose-phosphate isomerase inhibitor | 0.081 0.074 DBMET02038 0.107 0.042 DBMET02040 | DBMET02040 | |
| 0.043 | 0.115 | 0.128 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.074 0.056 DBMET02036 0.081 0.05 DBMET02038 0.078 0.053 DBMET02039 0.128 0.026 DBMET02040 | DBMET02040 | |
| 0.076 | 0.152 | 0.114 | TRPA1 agonist | 0.114 0.066 DBMET02036 0.105 0.08 DBMET02038 | DBMET02036 | |
| 0.165 | 0.251 | 0.361 | Toll-Like receptor agonist | 0.218 0.181 DBMET02035 0.249 0.149 DBMET02036 0.245 0.153 DBMET02038 0.21 0.189 DBMET02039 0.361 0.077 DBMET02040 | DBMET02040 | |
| 0.095 | 0.186 | 0.188 | Platelet adhesion inhibitor | 0.188 0.077 DBMET02034 | DBMET02034 | |
| 0.028 | 0.12 | 0.078 | Carbamoyl phosphate synthetase inhibitor | 0.078 0.029 DBMET02040 | DBMET02040 | |
| 0.026 | 0.121 | 0.045 | Kainate receptor agonist | 0.042 0.027 DBMET02035 0.045 0.02 DBMET02039 | DBMET02039 | |
| 0.051 | 0.149 | 0.102 | Alcohol dehydrogenase inhibitor | 0.102 0.05 DBMET02040 | DBMET02040 | |
| 0.043 | 0.158 | 0.089 | Butyrylcholinesterase inhibitor | 0.089 0.072 DBMET02040 | DBMET02040 | |
| 0.114 | 0.233 | 0.171 | Calpain inhibitor | 0.169 0.15 DBMET02036 0.165 0.156 DBMET02038 0.171 0.147 DBMET02039 | DBMET02039 | |
| 0.116 | 0.256 | 0.286 | Thyroid hormone antagonist | 0.218 0.146 DBMET02036 0.201 0.161 DBMET02038 0.286 0.101 DBMET02040 | DBMET02040 | |
| 0.036 | 0.179 | 0.065 | Glutamate (mGluR7) antagonist | 0.065 0.053 DBMET02039 | DBMET02039 | |
| 0.052 | 0.207 | 0.113 | Amylase inhibitor | 0.101 0.096 DBMET02034 0.113 0.086 DBMET02040 | DBMET02040 | |
| 0.123 | 0.28 | 0.186 | RNA-directed DNA polymerase inhibitor | 0.186 0.121 DBMET02040 | DBMET02040 | |
| 0.028 | 0.185 | 0.076 | Glutamate decarboxylase inhibitor | 0.076 0.048 DBMET02040 | DBMET02040 | |
| 0.134 | 0.292 | 0.292 | 15-Lipoxygenase inhibitor | 0.292 0.137 DBMET02036 0.277 0.145 DBMET02038 0.277 0.145 DBMET02040 | DBMET02036 | |
| 0.049 | 0.211 | 0.12 | Cyclooxygenase 2 inhibitor | 0.12 0.08 DBMET02040 | DBMET02040 | |
| 0.108 | 0.274 | 0.26 | Thyroid hormone beta antagonist | 0.184 0.169 DBMET02036 0.26 0.112 DBMET02040 | DBMET02040 | |
| 0.024 | 0.203 | 0.165 | Porphobilinogen synthase inhibitor | 0.165 0.017 DBMET02040 | DBMET02040 | |
| 0.058 | 0.238 | 0.177 | NADPH oxidase inhibitor | 0.109 0.098 DBMET02039 0.177 0.042 DBMET02040 | DBMET02040 | |
| 0.022 | 0.203 | 0.049 | Aldosterone antagonist | 0.049 0.031 DBMET02040 | DBMET02040 | |
| 0.128 | 0.321 | 0.337 | Toll-Like receptor 7 agonist | 0.213 0.186 DBMET02036 0.213 0.185 DBMET02038 0.337 0.089 DBMET02040 | DBMET02040 | |
| 0.037 | 0.256 | 0.165 | Ferrochelatase inhibitor | 0.165 0.032 DBMET02040 | DBMET02040 | |
| 0.134 | 0.359 | 0.214 | 5 Hydroxytryptamine uptake stimulant | 0.214 0.126 DBMET02040 | DBMET02040 | |
| 0.044 | 0.277 | 0.143 | Alpha-N-acetylglucosaminidase inhibitor | 0.143 0.059 DBMET02040 | DBMET02040 | |
| 0.015 | 0.257 | 0.071 | Biliverdin reductase inhibitor | 0.071 0.031 DBMET02040 | DBMET02040 | |
| 0.035 | 0.279 | 0.084 | Uric acid excretion stimulant | 0.084 0.076 DBMET02040 | DBMET02040 | |
| 0.034 | 0.323 | 0.07 | GABA B receptor agonist | 0.07 0.068 DBMET02040 | DBMET02040 | |
| 0.041 | 0.351 | 0.102 | DOPA decarboxylase inhibitor | 0.102 0.071 DBMET02040 | DBMET02040 | |
| 0.055 | 0.483 | 0.188 | Hypoxia-inducible factor 1 alpha inhibitor | 0.188 0.168 DBMET02040 | DBMET02040 | |
| 0.01 | 0.448 | 0.07 | Phenylalanine 4-hydroxylase inhibitor | 0.07 0.047 DBMET02040 | DBMET02040 | |
| 0.031 | 0.5 | 0.13 | Amyloid beta precursor protein antagonist | 0.13 0.126 DBMET02034 | DBMET02034 | |
| 0.099 | 0.625 | 0.231 | Calcium channel L-type activator | 0.231 0.228 DBMET02040 | DBMET02040 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |